Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 6385 - 6392 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCN4738 | Olivil monoacetate |
|
Prostephanaberrine is a natural product from Valeriana officinalis.
|
|
| BCN4739 | Barpisoflavone A |
|
1. Barpisoflavone A possesses moderate estrogen partial agonistic activities and moderate antioxidant activities.
|
|
| BCN4740 | Drevogenin A |
|
Standard reference
|
|
| BCN4741 | Stilbostemin N |
|
1. Stilbostemins N may exhibit moderate antibacterial activities.
|
|
| BCN4742 | Tephrosin |
|
1. Tephrosin may be valuable for augmenting the therapeutic efficacy of 2-Deoxy-D-glucose(DG), DG is currently under clinical evaluation for targeting tumor cells.
2. Tephrosin has potent antitumor activity by inducing autophagy pathway, internalization and degradation of inactivated EGFR and ErbB2. 3. Tephrosin could exert antitumor effects by inducing internalization and degradation of inactivated EGFR and ErbB2 in human colon cancer cells. |
|
| BCN4743 | Eriodictyol-7-O-glucoside |
|
1. Eriodictyol-7-O-glucoside and epicatechin appears to be responsible for the antioxidant activity of pistachio skin.
2. Eriodictyol-7-O-glucoside has protective effect on cisplatin-induced toxicity was investigated in a human renal mesangial cell line, HRMC. 3. Eriodictyol-7-O-glucoside can activate Nrf2/ARE signaling, directly associated with its neuroprotection against oxidative stress-induced ischemic; suggests that targeting the Nrf2/ARE pathway may be a promising approach for therapeutic intervention in stroke. |
|
| BCN4744 | Griffithinam |
|
Standard reference
|
|
| BCN4745 | Goniotriol |
|
1. Goniotriol exhibits antiplasmodial activity against Plasmodium falciparum (IC50=2.6 microg/mL).
2. Goniotriol shows antimycobacterial activity against Mycobacterium tuberculosis (MIC =100 microg/mL). 3. Goniotriol shows cytotoxicity against cancer cells, KB, BC1, NCI-H187, and MCF-7 with IC(50) ranging from 0.4 to 22.7 microg/mL. |
|